RecruitingNCT06455787

JOURNEY

J-Valve Transfemoral Pivotal Study

JC Medical, Inc., an affiliate of Edwards Lifesciences LLCMultiple US sitesView on ClinicalTrials.gov

AI Description

The primary objective of this study is to assess the safety and efficacy of the J-Valve Transfemoral (TF) System in patients with symptomatic, severe (grade 3 or 4), native aortic valve regurgitation (AR) and AR-dominant mixed aortic valve disease, who are judged by a multi-disciplinary heart team to be at high risk for open surgical aortic valve replacement (SAVR).

A Cardiac Magnetic Resonance (CMR) sub-study will examine if intervention for AR translates to improved ventricular remodeling, the impact of LV remodeling on clinical outcomes and quality of life, as well as volumetric and myocardial differences between genders.

Report inaccurate information

Who can join
adult, older adult
Participants
194
Expected completion
2032-02
Funded by
industry

Conditions studied

Aortic Valve Disease Mixed, Aortic Valve Regurgitation

What is being tested

  • DEVICE: J-Valve Transfemoral (TF) System

What it measures

  • All-cause mortality at 1 year, 1-year post-procedure
  • The composite rate of early-safety outcomes at 30 days as defined by the Valve Academic Research Consortium 3 (VARC-3), Includes: * All-cause death * All stroke * VARC-3 type 2-4 bleeding * Major vascular, access-related, or cardiac structural complication * Acute kidney injury (AKI) stage 3 or 4 * New permanent pacemaker due to procedure-related conduction abnormalities * Surgery or intervention related to the device, 30-days post-procedure

Working with

Cardiovascular Research Foundation, New York, Minneapolis Heart Institute Foundation

Centers Participating

These centers are participating in this study. Reach out to them directly to learn more.

Data Sources and Methodology

Registry entry updated 2026-05-04

Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.

If you would rather we did it with you, call us on (656) 206-4686.